Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach

Molecular Psychiatry

Volumn 20, Issue 11, 2015, Pages 1266-1285

  Niculescu, A B ^a,b,c   Levey, D F ^a,b   Phalen, P L ^c   Le Niculescu, H ^a   Dainton, H D ^a   Jain, N ^a   Belanger, E ^c   James, A ^c   George, S ^c   Weber, H ^a   Graham, D L ^a   Schweitzer, R ^a   Ladd, T B ^a   Learman, R ^a   Niculescu, E M ^a   Vanipenta, N P ^a   Khan, F N ^a   Mullen, J ^a   Shankar, G ^a   Cook, S ^d   Humbert, C ^d   Ballew, A ^d   Yard, M ^a   Gelbart, T ^e   Shekhar, A ^a   Schork, N J ^f   Kurian, S M ^e   Sandusky, G E ^a   Salomon, D R ^e   more..

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Marion County Prosecutor's Office   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

^f J CRAIG VENTER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CLOZAPINE; KETAMINE; LITHIUM; OMEGA 3 FATTY ACID;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CONVERGENT FUNCTIONAL GENOMICS; EXTRACELLULAR SPACE; FOLLOW UP; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENETIC VARIABILITY; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PANIC; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGULATORY MECHANISM; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SUICIDAL IDEATION; SUICIDE; COHORT ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; GENOMICS; MENTAL DISEASE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BIOMARKERS; COHORT STUDIES; DATABASES, GENETIC; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SUICIDE; YOUNG ADULT;

EID: 84946492005     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.112     Document Type: Article

References (41)

1. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009; 14: 156-174.
2. Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry 2011; 16: 37-58.
3. Niculescu AB, Levey D, Le-Niculescu H, Niculescu E, Kurian SM, Salomon D. Psychiatric blood biomarkers: avoiding jumping to premature negative or positive conclusions. Mol Psychiatry 2015; 20: 286-288.
4. Niculescu AB, Le-Niculescu H. Convergent Functional Genomics: what we have learned and can learn about genes, pathways, and mechanisms. Neuropsychopharmacology 2010; 35: 355-356.
5. Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ et al. PhenoChipping of psychotic disorders: A novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet B, Neuropsychiatr Genet 2006; 141B: 653-662.
6. Borges G, Angst J, Nock MK, Ruscio AM, Kessler RC. Risk factors for the incidence and persistence of suicide-related outcomes: A 10-year follow-up study using the National Comorbidity Surveys. J Affect Disord 2008; 105: 25-33.
7. Nock MK. Future directions for the study of suicide and self-injury. J Clin Child Adolesc Psychol 2012; 41: 255-259.
8. Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, Miriami E et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012; 148: 1293-1307.
9. Darlington TM, Pimentel R, Smith K, Bakian AV, Jerominski L, Cardon J et al. Identifying rare variants for genetic risk through a combined pedigree and phenotype approach: application to suicide and asthma. Transl Psychiatry 2014; 4: e471.
10. Sequeira A, Morgan L, Walsh DM, Cartagena PM, Choudary P, Li J et al. Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide. PLoS One 2012; 7: e35367.
11. Klempan TA, Sequeira A, Canetti L, Lalovic A, Ernst C, ffrench-Mullen J et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatry 2009; 14: 175-189.
12. Hishimoto A, Cui H, Mouri K, Nushida H, Ueno Y, Maeda K et al. A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J Neural Transm 2008; 115: 531-536.
13. Gabilondo AM, Meana JJ, Garcia-Sevilla JA. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res 1995; 682: 245-250.
14. Guintivano J, Brown T, Newcomer A, Jones M, Cox O, Maher BS et al. Identification and replication of a combined epigenetic and genetic biomarker predicting suicide and suicidal behaviors. Am J Psychiatry 2014; 171: 1287-1296.
15. Mann JJ, Currier D. Medication in suicide prevention insights from neurobiology of suicidal behavior. In: Dwivedi Y (ed) The Neurobiological Basis of Suicide. CRC Boca Raton (FL), 2012.
16. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006; 163: 1100-1102.
17. Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME et al. Toward a biosignature for suicide. Am J Psychiatry 2014; 171: 1259-1277.
18. Kelleher I, Lynch F, Harley M, Molloy C, Roddy S, Fitzpatrick C et al. Psychotic symptoms in adolescence index risk for suicidal behavior: findings from 2 population-based case-control clinical interview studies. Arch Gen Psychiatry 2012; 69: 1277-1283.
19. Schoenbaum M, Kessler RC, Gilman SE, Colpe LJ, Heeringa SG, Stein MB et al. Predictors of suicide and accident death in the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS): results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). JAMA Psychiatry 2014; 71: 493-503.
20. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 2011; 168: 1266-1277.
21. Wemmie JA, Taugher RJ, Kreple CJ. Acid-sensing ion channels in pain and disease. Nat Rev Neuroscience 2013; 14: 461-471.
22. Wasserman D, Hoven CW, Wasserman C, Wall M, Eisenberg R, Hadlaczky G et al. School-based suicide prevention programmes: The SEYLE cluster-randomised, controlled trial. Lancet 2015; 385: 1536-1544.
23. Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev 2008; 30: 133-154.
24. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010; 329: 959-964.
25. Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA et al. Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 2014; 58: 161-166.
26. Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC et al. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 2012; 46: 57-63.
27. Hoyo-Becerra C, Huebener A, Trippler M, Lutterbeck M, Liu ZJ, Truebner K et al. Concomitant interferon alpha stimulation and TLR3 activation induces neuronal expression of depression-related genes that are elevated in the brain of suicidal persons. PLoS One 2013; 8: e83149.
28. Lindqvist D, Janelidze S, Erhardt S, Traskman-Bendz L, Engstrom G, Brundin L. CSF biomarkers in suicide attempters-A principal component analysis. Acta Psychiatr Scand 2011; 124: 52-61.
29. Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Traskman-Bendz L, Guillemin GJ et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 2015; 43: 110-117.
30. Kim YK, Lee SW, Kim SH, Shim SH, Han SW, Choi SH et al. Differences in cytokines between non-suicidal patients and suicidal patients in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 356-361.
31. Fiori LM, Wanner B, Jomphe V, Croteau J, Vitaro F, Tremblay RE et al. Association of polyaminergic loci with anxiety, mood disorders, and attempted suicide. PloS One 2010; 5: e15146.
32. Sokolowski M, Ben-Efraim YJ, Wasserman J, Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry 2013; 18: 985-992.
33. Perlis RH, Huang J, Purcell S, Fava M, Rush AJ, Sullivan PF et al. Genome-wide association study of suicide attempts in mood disorder patients. Am J Psychiatry 2010; 167: 1499-1507.
34. Kim S, Choi KH, Baykiz AF, Gershenfeld HK. Suicide candidate genes associated with bipolar disorder and schizophrenia: An exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007; 8: 413.
35. Labonte B, Suderman M, Maussion G, Lopez JP, Navarro-Sanchez L, Yerko V et al. Genome-wide methylation changes in the brains of suicide completers. Am J Psychiatry 2013; 170: 511-520.
36. Seder E, Biselli A, Pisano S, Niccolai S, Smith GD, Joo K et al. Longitudinal target-spin asymmetries for deeply virtual compton scattering. Phys Rev Lett 2015; 114: 032001.
37. Roggenbach J, Muller-Oerlinghausen B, Franke L, Uebelhack R, Blank S, Ahrens B. Peripheral serotonergic markers in acutely suicidal patients. 1 Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects. J Neural Transm 2007; 114: 479-487
38. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR et al. Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. J Psychiatr Res 2003; 37: 421-432.
39. Punzi G, Ursini G, Shin JH, Kleinman JE, Hyde TM, Weinberger DR. Increased expression of MARCKS in post-mortem brain of violent suicide completers is related to transcription of a long, noncoding, antisense RNA. Mol Psychiatry 2014; 19: 1057-1059.
40. Dwivedi Y, Rizavi HS, Zhang H, Roberts RC, Conley RR, Pandey GN. Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects. Biol Psychiatry 2010; 67: 1017-1025.
41. Karege F, Perroud N, Burkhardt S, Fernandez R, Ballmann E, La Harpe R et al. Alterations in phosphatidylinositol 3-kinase activity and PTEN phosphatase in the prefrontal cortex of depressed suicide victims. Neuropsychobiology 2011; 63: 224-231.